Abstract
References
1.
Folkman
J.
. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995 ; 1 : 27 –31 .
2.
Bergers
G.
,
Benjamin
L.E.
. Tumorigenesis and the angiogenic switch. Nat Rev Cancer 2003 ; 3 : 401 –10 .
3.
O'Reilly
M.S.
,
Holmgren
L.
,
Shing
Y.
Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994 ; 79 : 315 –28 .
4.
Hogg
P.J.
. Plasmin reductase. In:
Waisman
D.M.
, ed. Plasminogen. New York : Kluwer Academic Publishers , 2003 ; 121 –31 .
5.
Lay
A.J.
,
Jiang
X-M
,
Kisker
O.
Phosphoglycerate kinase acts in tumour angiogenesis as a disulfide reductase. Nature 2000 ; 408 : 869 –73 .
6.
Bhattacharjee
A.
,
Richards
W.G.
,
Staunton
J.
Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci USA 2001 ; 98 : 13790 –5 .
7.
Chen
G.
,
Gharib
T.G.
,
Wang
H.
Protein profiles associated with survival in lung adenocarcinoma. Proc Natl Acad Sci USA 2003 ; 100 : 13537 –42 .
8.
Daly
E.B.
,
Wind
T.
,
Jiang
X-M
,
Sun
L.
,
Hogg
P.J.
. Secretion of phosphoglycerate kinase from tumour cells is controlled by oxygen-sensing hydroxylases. Biochim Biophys Acta 2004 ; 1691 : 41 –6 .